YOKOWO (6800) FY2027 Q1 Earnings Report

Quick View

Executive Summary

Double-digit revenue growth, combined with a significant improvement in the profitability of the CTC Business, resulted in substantial increases in Operating Income, Ordinary Income, and Net Income. Revenue was ¥259.2B (+23.4% YoY), Operating Income was ¥20.0B (+172.7%), Ordinary Income was ¥21.9B (+601.8%), and Net Income attributable to owners of the parent was ¥17.1B (+433.1%). The Operating Income margin improved significantly to 7.7% from approximately 3.5% in the same period of the previous year, and profit growth exceeding revenue growth was primarily attributable to the increased profitability of the CTC segment.

Factors Affecting Business Performance

【Revenue】Revenue was ¥259.2B, an increase of +23.4% YoY. By segment, CTC posted the largest increase at ¥74.5B (+70.4%), while VCCS had the largest revenue scale at ¥142.5B (+4.7%), although its growth was moderate. FCMD expanded to ¥31.9B (+19.6%), and the Incubation Center grew sharply to ¥10.2B (+195.1%). By region, revenue was ¥80.3B in Japan (+22.9%), ¥100.6B in Europe and the Americas (+11.2%), and ¥78.2B in Asia (+44.4%); the sharp growth in Asia was primarily driven by the expansion of CTC revenue in the region.

【Profit and Loss】Operating Income was ¥20.0B (+172.7%), with the Operating Income margin improving by approximately 4.2pt YoY to 7.7%. CTC’s Operating Income was ¥19.7B (+799.5%), with a 26.4% margin, accounting for the majority of consolidated profit. In contrast, VCCS posted ¥1.2B (-81.1%) and FCMD posted ¥0.8B (-3.4%), both remaining at low profitability levels, while the Incubation Center posted a loss of -¥1.7B, although the loss narrowed. Ordinary Income reached ¥21.9B (+601.8%), also boosted by foreign exchange gains of ¥1.7B. Extraordinary income and losses consisted solely of a ¥0.1B loss on disposal and sale of fixed assets, indicating limited temporary factors; Net Income of ¥17.1B was largely supported by recurring business profits. The Company achieved both revenue and profit growth, with CTC serving as the primary driver of profit growth.

Segment Analysis

CTC recorded Revenue of ¥74.5B (+70.4%), Operating Income of ¥19.7B (+799.5%), and a 26.4% margin, making it the most profitable segment and accounting for the majority of consolidated Operating Income of ¥20.0B. VCCS had the largest revenue scale at ¥142.5B (+4.7%), but Operating Income declined substantially to ¥1.2B (-81.1%), with the margin falling to 0.8% from ¥6.2B in the same period of the previous year. FCMD recorded Revenue of ¥31.9B (+19.6%) and Operating Income of ¥0.8B (-3.4%), resulting in a margin of only 2.7%. The Incubation Center expanded sharply, with Revenue of ¥10.2B (+195.1%), while its Operating Loss narrowed to -¥1.7B from -¥2.0B in the same period of the previous year. Consolidated profit is highly concentrated in CTC, and the decline in VCCS’s profitability could become a constraint on sustainable earnings growth.

Key Financial Indicators

【Profitability】The Operating Income margin of 7.7% improved significantly from approximately 3.5% in the same period of the previous year, while the Net Income margin also increased to 6.6% from approximately 3.2%. ROE was 2.8% (based on simple Q1 actual results), and on an annualized basis is expected to reach a higher level, reflecting the improvement in profitability.【Cash Flow Quality】Accounts receivable were ¥193.3B, accounting for 20.5% of total assets, indicating an expansion in working capital accompanying revenue growth. Inventories were ¥86.0B, primarily consisting of ¥86.0B in finished products.【Investment Efficiency】Investment securities were ¥59.2B, while intangible fixed assets were ¥22.8B, representing a small 2.4% of total assets; the asset composition is centered on tangible assets.【Financial Soundness】The Equity Ratio declined slightly to 66.3% from 67.4% in the previous year but remained at a high level. Interest-bearing debt was limited, with long-term borrowings of ¥71.8B compared with cash and deposits of ¥181.7B, and the financial foundation can be assessed as sound.

Cash Flow Analysis

As no statement of cash flows has been disclosed, funding trends are analyzed based on changes in the balance sheet. Cash and deposits were ¥181.7B, nearly unchanged from ¥181.7B in the same period of the previous year, indicating that the level of liquidity on hand was maintained even amid earnings growth. Meanwhile, accounts receivable increased to ¥193.3B from ¥183.8B in the same period of the previous year, reflecting an expansion in working capital accompanying revenue growth. Accounts payable also increased to ¥85.6B from ¥75.2B, indicating an expansion in transaction volumes on both the procurement and payment sides. Interest-bearing debt totaled ¥114.0B, comprising short-term borrowings of ¥42.2B and long-term borrowings of ¥71.8B. As this was below cash and deposits of ¥181.7B, the Company remained in a net cash position, and its financial funding capacity was maintained even during the earnings expansion phase.

Earnings Quality

Foreign exchange gains of ¥1.7B, a factor contributing to the increase in Ordinary Income, were equivalent to 8.3% of Operating Income of ¥20.0B and significantly expanded Ordinary Income separately from the increase in operating earnings; they are an item with a strongly temporary nature. Extraordinary income and losses consisted solely of a ¥0.1B loss on disposal and sale of fixed assets, and Net Income of ¥17.1B was primarily supported by improved profitability at the operating level. Unlike the ¥3.1B gain on bargain purchase recognized in the same period of the previous year, no temporary extraordinary gain occurred in the current period, and the quality of Net Income was closer to underlying operating performance than in the same period of the previous year. Comprehensive Income was ¥29.0B, exceeding Net Income of ¥17.2B, primarily due to foreign currency translation adjustments of ¥5.9B and valuation differences on securities of ¥6.8B. This divergence reflects market-related factors and should be distinguished from recurring earnings power. If the pace of increase in accounts receivable exceeds revenue growth, attention should be paid to the speed of profit conversion into cash from an accrual perspective.

Earnings Forecast and Guidance

The full-year earnings forecast is Revenue of ¥1,010.0B (+12.1% YoY), Operating Income of ¥80.0B (+59.5%), and Ordinary Income of ¥79.0B (+42.9%). Progress rates in Q1 were 25.7% for Revenue, 25.0% for Operating Income, and 27.7% for Ordinary Income; Operating Income was broadly in line with the standard quarterly progress rate of 25%. The excess progress of Ordinary Income was largely attributable to foreign exchange gains and may fluctuate depending on foreign exchange conditions over the full year. The forecast full-year Operating Income margin is 7.9%, close to the Q1 actual result of 7.7%, suggesting that the Company assumes the current profitability level will broadly continue throughout the year. The earnings forecast was revised during the quarter.

Shareholder Returns

The full-year dividend forecast is ¥64.00 per share. The Payout Ratio against forecast full-year EPS of ¥240.17 is approximately 26.6%, below the general benchmark for sustainability. There was no revision to the dividend forecast during the quarter. In addition to the Company’s net cash position, with cash and deposits of ¥181.7B against interest-bearing debt of ¥114.0B, its financial foundation, including an Equity Ratio of 66.3%, indicates that the current dividend forecast is a reasonable level from both earnings and financial perspectives.

Risk Factors

1. Concentration of earnings by segment: CTC’s Operating Income of ¥19.7B accounts for the majority of consolidated Operating Income of ¥20.0B, meaning that demand trends and pricing conditions in this business directly affect the Company-wide profit margin.

2. Deterioration in the profitability of the core business: VCCS, the largest segment by Revenue, saw Operating Income decline 81.1% YoY to ¥1.2B, with its margin falling to 0.8%. Continued low profitability in the core business could affect the sustainability of consolidated earnings growth.

3. Increase in trade receivables: Accounts receivable of ¥193.3B increased from ¥183.8B in the same period of the previous year and accounted for 20.5% of total assets. The impact of working capital expansion accompanying revenue growth on future funding should be closely monitored.

Industry Benchmark (Reference; Compiled by the Company)

Industry Benchmark (manufacturing)

Profitability and Returns

Both the Operating Income margin and Net Income margin are slightly below the industry median but remain within the interquartile range.

Growth and Capital Efficiency

The Revenue growth rate is substantially above the industry median and exceeds the upper quartile.

※Source: Compiled by the Company

Key Points from the Earnings Results

1. The Company achieved both revenue and profit growth in Q1, with the Operating Income margin improving by approximately 4.2pt YoY. The primary drivers were revenue expansion and increased profitability in the CTC segment, resulting in an earnings structure with a high concentration of profit in that business.

2. VCCS, the largest segment by Revenue, saw Operating Income decline 81.1% YoY. The earnings trends of businesses other than CTC are therefore important for assessing the quality of consolidated performance.

3. While the progress rate for Operating Income against the full-year forecast was 25.0%, a standard level, the progress rates for Ordinary Income and Net Income were relatively high, partly due to the contribution from foreign exchange gains. The sustainability of this difference will need to be monitored in subsequent quarters.

Theoretical Share Price (Reference Value)

Sensitivity: ¥2,599–¥2,752 at ±1% for the cost of equity, and ¥2,673–¥2,674 at ±0.1 for ω.

Notes:

• Because forecast ROE is below the cost of equity, the theoretical value is below book value per share.
• Net assets as of the end of the quarter are used (there is a timing difference from the full-year forecast).
• As net assets include non-controlling interests, the theoretical value may be calculated at a slightly elevated level.

(Calculation model: Residual Income Model (Ohlson-type; explicit 5-year fade) / Interest rate reference month: 2026-07 / Mechanically calculated solely from publicly disclosed data; this is not a forecast of the market share price or a recommendation of any specific investment action, and does not predict or guarantee future share prices.)

---

This report is an earnings analysis document automatically generated by AI based on XBRL earnings release data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own responsibility, after consulting with professionals as necessary.

---End of Report---

---

AI Financial Analysis

Executive Summary

FY2027 Q1 was a strong start, with revenue growth translating into a material recovery in operating and net profitability. Revenue rose 23.4% YoY to ¥25.92bn. Operating income increased 172.7% to ¥2.00bn. Net income attributable to owners increased 433.1% to ¥1.71bn. The operating margin expanded to 7.7% from 3.5% a year earlier, a 423bp improvement. Gross margin increased to 21.6% from 18.1%, an expansion of approximately 344bp. This gross-margin recovery was the principal driver of earnings leverage. SG&A rose 16.7% to ¥3.59bn, below revenue growth, creating favorable operating leverage. Ordinary income rose more sharply than operating income, reaching ¥2.19bn, supported by a ¥0.17bn FX gain. FX gains represented 8.3% of operating income, making exchange-rate movements relevant but not the central explanation for the profit recovery. The CTC segment was the clear earnings engine, generating ¥1.97bn of segment profit, or almost all consolidated operating income. By contrast, VCCS profitability declined substantially despite modest sales growth, indicating an unfavorable product, customer, or cost mix within that segment. The incubation center's loss narrowed modestly while its revenue nearly tripled, although the segment remains loss-making. The Q1 revenue progress rate of 25.7% is essentially in line with the full-year forecast, while operating-income progress of 25.0% is exactly in line with the seasonal benchmark. Net-income progress of 30.5% is ahead of the 25% benchmark, partly reflecting favorable non-operating FX income and a lower effective tax rate. Full-year guidance implies ¥101.0bn of revenue, ¥8.0bn of operating income and ¥5.6bn of net income attributable to owners, and Q1 performance supports the revised outlook without establishing a clear basis for further forecast upside. The balance sheet remains conservatively financed, with substantial liquidity and moderate leverage. The principal operating item to monitor is the 68-day receivables collection period, which is elevated for manufacturing and can constrain cash conversion if it persists.

Profitability Analysis

Annualized DuPont ROE was 10.9%, comprising a 6.6% net profit margin, 1.100x annualized asset turnover, and 1.51x financial leverage. The return profile is therefore driven primarily by improved profitability rather than aggressive balance-sheet leverage. The largest YoY change was margin expansion: gross margin rose approximately 344bp to 21.6%, while operating margin rose 423bp to 7.7%. Revenue increased ¥4.91bn, whereas SG&A increased only ¥0.51bn, demonstrating favorable operating leverage. Cost of sales increased 18.2%, materially below the 23.4% revenue increase, which indicates improved production economics and/or sales mix. Net margin expanded approximately 506bp to 6.6% from 1.5%. CTC was the core business by operating-income contribution, with revenue of ¥7.45bn, up 70.4% YoY, and segment profit of ¥1.97bn, up from ¥0.22bn; its segment margin was 26.4%. VCCS remained the largest sales segment at ¥14.25bn, up 4.7%, but segment profit fell 81.1% to ¥0.12bn and its margin compressed to 0.8% from 4.5%. FC・MD revenue rose 19.6% to ¥3.19bn while segment profit was broadly flat at ¥0.09bn, leaving a 2.7% margin. Incubation center revenue rose to ¥1.02bn from ¥0.35bn, while its segment loss narrowed to ¥0.17bn from ¥0.20bn; its negative 17.0% margin remains dilutive. The tax burden factor of 0.783 and effective tax rate of 21.1% were supportive of post-tax returns, while the interest burden factor of 1.089 reflects net non-operating income rather than debt stress. Interest coverage of 32.8x confirms that interest costs do not currently limit earnings capacity.

Growth Assessment

Growth was broad-based geographically, with Japanese sales rising 22.9% to ¥8.03bn, European and U.S. sales rising 11.2% to ¥10.06bn, and Asian sales rising 44.4% to ¥7.82bn. CTC was the dominant source of incremental sales and the overwhelmingly dominant source of incremental segment earnings, suggesting that the quality of group growth depends on sustaining CTC demand and margins. VCCS sales growth was modest and did not convert into profit, making a recovery in this segment important for a more balanced earnings base. FC・MD delivered solid top-line growth but limited incremental profit, indicating that margin conversion remains an execution issue. The incubation center's strong sales expansion and narrower loss are constructive, but its negative margin means it remains an investment phase business rather than a current earnings contributor. Full-year guidance calls for 12.1% revenue growth and 59.5% operating-income growth; Q1 revenue has progressed 25.7% against the standard 25% pace and operating income 25.0% against the same benchmark. Ordinary-income progress is 27.7% and net-income progress is 30.5%, both modestly ahead of the seasonal benchmark. The latter outperformance should be interpreted cautiously because Q1 ordinary income benefited from FX gains of ¥0.17bn. Current-period extraordinary items were immaterial, with ¥0.03bn of gains and ¥0.10bn of losses, so Q1 earnings were principally generated through operating performance. In the prior-year quarter, a ¥0.31bn gain on negative goodwill had benefited extraordinary income; its absence in the current quarter reinforces the improvement in underlying operating and ordinary earnings.

Financial Health

Liquidity is strong, with a current ratio of 278.6%, a quick ratio of 237.2%, and working capital of ¥37.09bn. Cash and deposits of ¥18.17bn cover short-term loans of ¥4.22bn by 4.30x. Current assets of ¥57.86bn also substantially exceed current liabilities of ¥20.76bn, limiting near-term refinancing and maturity-mismatch risk. Interest-bearing debt was ¥11.40bn, consisting of ¥4.22bn in short-term loans and ¥7.18bn in long-term loans. Debt-to-equity of 0.51x, debt-to-capital of 15.4%, and financial leverage of 1.51x indicate a conservative capital structure. Long-term loans increased ¥1.00bn YoY to ¥7.18bn, while short-term loans increased ¥1.02bn, or 31.6%, to ¥4.22bn. The short-term debt increase warrants monitoring because it increased faster than revenue, although cash coverage and the current ratio remain ample. Investment securities increased ¥1.61bn, or 37.5%, to ¥5.92bn and represent 6.3% of total assets. This increase contributed to comprehensive income through valuation gains and adds exposure to market-price volatility, although it does not impair present solvency. Equity increased to ¥62.53bn from ¥60.34bn, aided by retained earnings and positive other comprehensive income. Total comprehensive income was ¥2.90bn, exceeding net income of ¥1.72bn, including ¥0.68bn of valuation gains on securities and ¥0.59bn of foreign-currency translation gains.

Notable B/S Changes

Investment securities: +¥1.61bn (+37.5%) to ¥5.92bn - increased marketable-investment exposure and contributed to valuation-related comprehensive-income volatility. Short-term loans: +¥1.02bn (+31.6%) to ¥4.22bn - increased reliance on short-term funding, although cash coverage of 4.30x and the 278.6% current ratio preserve substantial liquidity. Work in process: +¥1.43bn (+26.1%) to ¥0.69bn - indicates an increase in production-stage inventory and merits monitoring alongside production throughput and order fulfillment.

Cash Flow Quality

Dividend Sustainability

The full-year dividend forecast is ¥64 per share, against forecast EPS of ¥240.17. This implies a forecast dividend payout ratio of approximately 26.6%, which is conservative relative to the 60% sustainability benchmark. Retained earnings were ¥33.29bn, providing a substantial accounting buffer for distributions. Treasury shares totaled 0.53m shares, or roughly 2.2% of issued shares, while treasury stock was recorded at ¥1.01bn. The stated dividend policy was unchanged despite the earnings-forecast revision. The low forecast payout leaves room to retain capital for working-capital needs, capacity investment, and balance-sheet flexibility.

Risk Assessment

Business risks include CTC concentration: CTC generated ¥1.97bn of ¥2.00bn consolidated operating income. Any demand, pricing, execution, or product-cycle disruption in this segment would have an outsized effect on consolidated earnings., VCCS margin deterioration: VCCS segment profit fell 81.1% YoY to ¥0.12bn despite 4.7% sales growth, reducing its margin to 0.8%. A sustained lack of margin recovery would constrain group earnings diversification., Foreign-exchange exposure: Q1 included a ¥0.17bn FX gain, equivalent to 8.3% of operating income, and overseas revenue accounted for 69.0% of total sales. Exchange-rate volatility can affect both reported profit and the competitiveness of internationally supplied products., Manufacturing working-capital risk: Receivable days were 68 days, above the 60-day warning threshold. The elevated collection cycle may reflect customer terms, shipment timing, or slower cash collection, and could weaken cash conversion if maintained., Regional demand risk: Asia represented ¥7.82bn of revenue and grew 44.4% YoY. The growth contribution is significant, but it also increases sensitivity to regional electronics, automotive, industrial, and customer-capex cycles..

Financial risks include Short-term loans increased 31.6% YoY to ¥4.22bn. Liquidity is currently ample, but further short-term borrowing growth should be assessed against operating cash generation and receivables collection., Investment securities increased 37.5% YoY to ¥5.92bn. Valuation movements already contributed to other comprehensive income and may introduce equity volatility., Interest-bearing debt totaled ¥11.40bn. This is manageable given 32.8x interest coverage, 0.51x debt-to-equity, and cash of ¥18.17bn, but higher rates would increase financing costs over time..

Key concerns include HIGH_RECEIVABLE_DAYS alert: DSO of 68 days exceeds the 60-day warning threshold. The root cause is a receivables balance of ¥19.34bn relative to annualized Q1 revenue. This collection period is slower than the manufacturing benchmark and raises the risk that accounting profit converts less efficiently into cash. Its investment impact is currently moderated by high liquidity, but improvement in receivable days is important for validating earnings quality., Profit concentration in CTC is unusually high in Q1, while VCCS and FC・MD delivered low margins and the incubation center remained loss-making., Q1 net-income outperformance versus the full-year seasonal benchmark includes non-operating FX gains; recurring operating execution, particularly CTC margins and VCCS recovery, is more important than extrapolating the reported net-income progress rate..

Investment Implications

Key takeaways include Revenue growth of 23.4% and operating-income growth of 172.7% produced a 423bp operating-margin expansion to 7.7%., CTC is the core business and generated ¥1.97bn of segment profit on a 26.4% margin, but this creates meaningful earnings concentration., The balance sheet is strong: current ratio 278.6%, cash/short-term debt 4.30x, debt-to-equity 0.51x, and interest coverage 32.8x., The ¥64 full-year DPS forecast implies a conservative 26.6% payout ratio based on forecast EPS., Receivable days of 68 are the key operating-quality metric requiring monitoring..

Metrics to watch include CTC revenue growth and segment margin, VCCS segment-profit recovery and margin normalization, Receivable days and receivables growth relative to sales, FX gains or losses relative to operating income, Short-term loan balances and cash coverage, Progress against ¥101.0bn revenue, ¥8.0bn operating-income, and ¥5.6bn net-income full-year forecasts.

Regarding relative positioning, The company combines a solid 10.9% annualized ROE, strong liquidity, and conservative leverage with an operating margin that has improved into the mid-single-to-high-single-digit range. Its current profitability profile is stronger than the prior-year quarter but remains below the >8% operating-margin benchmark for a clearly strong industrial earnings profile. The primary differentiator is high-margin CTC growth; the primary constraint is uneven profitability across the remaining segments and slower-than-benchmark receivables collection.